Fundraising Fox

Kiffik Biomedical

Providence, US · Founded 2021 · Delaware corporation

KIFFIK develops the K-EXP platform for non-invasive, repeated access to interstitial fluid (ISF), the molecular environment around living cells, enabling earlier biological measurement than conventional blood testing. The platform targets biomarker discovery, longitudinal PK/PD and therapeutic response evaluation, and real-world physiological monitoring for research and clinical development.

Founders & leadership

GCGeorge Cagna
George CagnaChief Executive Officer
NM
Nicholas MarrChief Operation Officer
HP
Howard PetersonChief Commercial Officer and Board Secretary

Board

BD
Brian DouganChairman of the Board
BC
Blake CarverBoard Member

Reported raises · per SEC filings

Form D private placements

$830K disclosed across 1 round · 2021

$830KraisedJun 2022 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George CagnaExecutive Officer, Director, Promoter
  • Brian DouganExecutive Officer, Director, Promoter
  • Nicholas MarrExecutive Officer, Director, Promoter
  • Blake CarverDirector
  • Howard PetersonExecutive Officer, Director
Offering amount
$15M
Amount sold
$830K
Minimum investment
$10K
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
EKF Diagnostics4 shared keywordsEKF Diagnostics develops and manufactures point-of-care in-vitro diagnostic (IVD) medical devices and tests, along with reagents, enzymes, and central-laboratory analysis tools for healthcare providers, clinicians, and researchers. It serves the medical, biotechnology, and pharmaceutical industries, with manufacturing in the USA and Germany and distribution to over 120 countries.
Science Corporation3 shared keywordsScience Corporation develops brain-computer interface and neural engineering technology to restore vision, cognition, and mobility to patients with debilitating conditions. The company also provides components and vertically integrated infrastructure through Science Foundry to support innovation across the neural technology industry.
bio3 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
IQVIA3 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.

Companies competing with Kiffik Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Kiffik Biomedical do?
KIFFIK develops the K-EXP platform for non-invasive, repeated access to interstitial fluid (ISF), the molecular environment around living cells, enabling earlier biological measurement than conventional blood testing. The platform targets biomarker discovery, longitudinal PK/PD and therapeutic response evaluation, and real-world physiological monitoring for research and clinical development.
How much funding has Kiffik Biomedical raised?
Kiffik Biomedical has disclosed $830K raised across 1 round.
Where is Kiffik Biomedical headquartered?
Kiffik Biomedical is headquartered in Providence, US.